Advanced search
Publication Cover
Expert Review of Neurotherapeutics Volume 17, 2017 - Issue 4
Submit an article Journal homepage
2,864
Views
4
CrossRef citations to date
0
Altmetric
Editorial

The challenges of developing a gene therapy for amyotrophic lateral sclerosis

Muhibullah Sayed ToraDepartment of Neurological Surgery, Emory University, Atlanta, GA, USA;Coulter Department of Biomedical Engineering, Georgia Institute of Technology, Atlanta, GA, USAView further author information
,
Orion Paul Keifer Jr.Department of Neurological Surgery, Emory University, Atlanta, GA, USAView further author information
,
Jason John LamannaDepartment of Neurological Surgery, Emory University, Atlanta, GA, USAView further author information
&
Nicholas M BoulisDepartment of Neurological Surgery, Emory University, Atlanta, GA, USACorrespondence[email protected]
View further author information
Pages 323-325 | Received 12 Dec 2016, Accepted 24 Jan 2017, Published online: 22 Feb 2017

References

  • Peters OM, Ghasemi M, Brown RH Jr. Emerging mechanisms of molecular pathology in ALS. J Clin Invest. 2015;125:2548.
  • O’Connor DM, Boulis NM. Gene therapy for neurodegenerative diseases. Trends Mol Med. 2015;21:504–512.
  • Picher-Martel V, Valdmanis PN, Gould PV, Julien JP, Dupre N. From animal models to human disease: a genetic approach for personalized medicine in ALS. Acta neuropathologica communications. 2016;4:70.
  • Byrne S, Walsh C, Lynch C, et al. Rate of familial amyotrophic lateral sclerosis: a systematic review and meta-analysis. J Neurol Neurosurg Psychiatry. 2011;82:623–627.
  • Scarrott JM, Herranz-Martin S, Alrafiah AR, et al. Current developments in gene therapy for amyotrophic lateral sclerosis. Expert Opin Biol Ther. 2015;15:935–947.
  • DeJesus-Hernandez M, Mackenzie IR, Boeve BF, et al. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron. 2011;72:245–256.
  • Kenna KP, Van Doormaal PT, Dekker AM, et al. NEK1 variants confer susceptibility to amyotrophic lateral sclerosis. Nat Genet. 2016;48:1037–1042.
  • Golby R, Poirier B, Fabros M, et al. Five-year incidence of amyotrophic lateral sclerosis in British Columbia (2010-2015). Canadian Journal Neurological Sciences Le Journal Canadien Des Sciences Neurologiques. 2016;43(6):791–795.
  • Umoh ME, Fournier C, Li Y, et al. Comparative analysis of C9orf72 and sporadic disease in an ALS clinic population. Neurology. 2016;87:1024–1030.
  • Foust KD, Salazar DL, Likhite S. et al. Therapeutic AAV9-mediated suppression of mutant SOD1 slows disease progression and extends survival in models of inherited ALS. Mol Ther. 2013;21(12):2148–2159.
  • Stoica L, Todeasa SH, Cabrera GT, et al. Adeno-associated virus-delivered artificial microRNA extends survival and delays paralysis in an amyotrophic lateral sclerosis mouse model. Ann Neurol. 2016;79:687–700.
  • Benkler C, Barhum Y, Ben-Zur T, et al. Multifactorial gene therapy enhancing the glutamate uptake system and reducing oxidative stress delays symptom onset and prolongs survival in the SOD1-G93A ALS mouse model. J Mol Neurosci. 2016;58:46–58.
  • Sances S, Bruijn LI, Chandran S, et al. Modeling ALS with motor neurons derived from human induced pluripotent stem cells. Nat Neurosci. 2016;19:542–553.
  • Yang H, Wang G, Sun H, et al. Species-dependent neuropathology in transgenic SOD1 pigs. Cell Res. 2014;24:464–481.
  • Tu Z, Yang W, Yan S, et al. CRISPR/Cas9: a powerful genetic engineering tool for establishing large animal models of neurodegenerative diseases. Mol Neurodegener. 2015;10:35.
  • Choudhury SR, Hudry E, Maguire CA, et al. Viral vectors for therapy of neurologic diseases. Neuropharmacology. 2016Feb 21. pii: S0028-3908(16)30048-X.
  • Hirano M, Kato S, Kobayashi K, et al. Highly efficient retrograde gene transfer into motor neurons by a lentiviral vector pseudotyped with fusion glycoprotein. Plos One. 2013;8:e75896.
  • Suzuki M, Svendsen CN. Ex vivo gene therapy using human mesenchymal stem cells to deliver growth factors in the skeletal muscle of a familial ALS rat model. Methods Mol Biol. 2016;1382:325–336.
  • Stewart S. Press release: cedars-Sinai receives approval to test novel combined stem cell and gene therapy for ALS patients.Los Angeles, CA: Cedars-Sinai; 2016.
  • Saraiva J, Nobre RJ, De Almeida LP. Gene therapy for the CNS using AAVs: the impact of systemic delivery by AAV9. Journal of controlled release: official journal of the Controlled Release Society; 2016;241:94–109.
  • Federici T, Boulis NM. Gene therapy for amyotrophic lateral sclerosis. Neurobiol Dis. 2012;48:236–242.
  • Mendell JR. Phase I gene transfer clinical trial for spinal muscular atrophy type 1 delivering AVXS-101. In: ClinicalTrials.gov [internet]. Bethesda (MD): National Library of Medicine (US); 2014-2016. 2014. Available from: https://clinicaltrials.gov/ct2/show/record/NCT02122952.
  • Federici T, Riley J, Park J, et al. Preclinical safety validation of a stabilized viral vector direct injection approach to the cervical spinal cord. Clin Transl Sci. 2009;2:165–167.
  • Mazzini L, Gelati M, Profico DC, et al. Human neural stem cell transplantation in ALS: initial results from a phase I trial. J Transl Med. 2015;13:17.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.